[HTML][HTML] Variability of serum CYFRA 21− 1 and its susceptibility to clinical characteristics in individuals without cancer: a 4-year retrospective analysis
A Minamibata, Y Kono, T Arimoto, Y Marunaka… - BMC Pulmonary …, 2023 - Springer
Background CYFRA 21− 1 is a useful marker for diagnosing and monitoring lung cancer.
However, its stability remains unclear. Moreover, while its applicability to screening is now …
However, its stability remains unclear. Moreover, while its applicability to screening is now …
[HTML][HTML] Variability of serum CYFRA 21− 1 and its susceptibility to clinical characteristics in individuals without cancer: a 4-year retrospective analysis
A Minamibata, Y Kono, T Arimoto… - BMC Pulmonary …, 2023 - ncbi.nlm.nih.gov
Background CYFRA 21− 1 is a useful marker for diagnosing and monitoring lung cancer.
However, its stability remains unclear. Moreover, while its applicability to screening is now …
However, its stability remains unclear. Moreover, while its applicability to screening is now …
[HTML][HTML] Variability of serum CYFRA 21− 1 and its susceptibility to clinical characteristics in individuals without cancer: a 4-year retrospective analysis
A Minamibata, Y Kono… - BMC …, 2023 - bmcpulmmed.biomedcentral.com
CYFRA 21− 1 is a useful marker for diagnosing and monitoring lung cancer. However, its
stability remains unclear. Moreover, while its applicability to screening is now being …
stability remains unclear. Moreover, while its applicability to screening is now being …
Variability of serum CYFRA 21− 1 and its susceptibility to clinical characteristics in individuals without cancer: a 4-year retrospective analysis
A Minamibata, Y Kono, T Arimoto… - BMC Pulmonary …, 2023 - search.proquest.com
Background CYFRA 21− 1 is a useful marker for diagnosing and monitoring lung cancer.
However, its stability remains unclear. Moreover, while its applicability to screening is now …
However, its stability remains unclear. Moreover, while its applicability to screening is now …
Variability of serum CYFRA 21-1 and its susceptibility to clinical characteristics in individuals without cancer: a 4-year retrospective analysis
A Minamibata, Y Kono, T Arimoto… - BMC pulmonary …, 2023 - pubmed.ncbi.nlm.nih.gov
Background CYFRA 21-1 is a useful marker for diagnosing and monitoring lung cancer.
However, its stability remains unclear. Moreover, while its applicability to screening is now …
However, its stability remains unclear. Moreover, while its applicability to screening is now …
Variability of serum CYFRA 21-1 and its susceptibility to clinical characteristics in individuals without cancer: a 4-year retrospective analysis.
A Minamibata, Y Kono, T Arimoto… - BMC Pulmonary …, 2023 - europepmc.org
Background CYFRA 21-1 is a useful marker for diagnosing and monitoring lung cancer.
However, its stability remains unclear. Moreover, while its applicability to screening is now …
However, its stability remains unclear. Moreover, while its applicability to screening is now …
Variability of serum CYFRA 21− 1 and its susceptibility to clinical characteristics in individuals without cancer: a 4-year retrospective analysis.
A Minamibata, Y Kono, T Arimoto… - BMC Pulmonary …, 2023 - search.ebscohost.com
Abstract Background: CYFRA 21− 1 is a useful marker for diagnosing and monitoring lung
cancer. However, its stability remains unclear. Moreover, while its applicability to screening …
cancer. However, its stability remains unclear. Moreover, while its applicability to screening …
[PDF][PDF] Variability of serum CYFRA 21− 1 and its susceptibility to clinical characteristics in individuals without cancer: a 4-year retrospective analysis
A Minamibata, Y Kono, T Arimoto, Y Marunaka… - 2023 - bmcpulmmed.biomedcentral.com
Background CYFRA 21− 1 is a useful marker for diagnosing and monitoring lung cancer.
However, its stability remains unclear. Moreover, while its applicability to screening is now …
However, its stability remains unclear. Moreover, while its applicability to screening is now …
[引用][C] Variability of serum CYFRA 21− 1 and its susceptibility to clinical characteristics in individuals without cancer: a 4-year retrospective analysis
A Minamibata, Y Kono, T Arimoto, Y Marunaka… - 2023 - europepmc.org
Background CYFRA 21− 1 is a useful marker for diagnosing and monitoring lung cancer.
However, its stability remains unclear. Moreover, while its applicability to screening is now …
However, its stability remains unclear. Moreover, while its applicability to screening is now …